Results 21 to 30 of about 30,157 (163)

Blood Damage in Ventricular Assist Devices [PDF]

The International Journal of Artificial Organs, 2016
Advancements in both the design of mechanical circulatory support (MCS) and medical care for recipients have led to steady improvements in patient survival over the last decades. Indeed, current generations of ventricular assist devices (VADs), for example, provide important therapeutic alternatives for individuals with heart failure that may be ...
Simmonds, M, Thamsen, B, Kertzscher, U
openaire   +6 more sources

Targeted myocardial gene expression in failing hearts by RNA sequencing

Journal of Translational Medicine, 2016
Background Myocardial recovery with left ventricular assist device (LVAD) therapy is highly variable and difficult to predict. Next generation ribonucleic acid (RNA) sequencing is an innovative, rapid, and quantitative approach to gene expression ...
Kajari Dhar, Alexandra M. Moulton, Eric Rome, Fang Qiu, Jeff Kittrell, Eugenia Raichlin, Ronald Zolty, John Y. Um, Michael J. Moulton, Hesham Basma, Daniel R. Anderson, James D. Eudy, Brian D. Lowes   +12 more
doaj   +1 more source

Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report

Journal of Medical Case Reports, 2017
Background Fulminant myocarditis is a life-threatening disease, and myocardial damage expands the right ventricle as well as the left ventricle in some cases.
Yusuke Adachi, Osamu Kinoshita, Masaru Hatano, Yukako Shintani, Noritsugu Naito, Mitsutoshi Kimura, Kan Nawata, Daisuke Nitta, Hisataka Maki, Kazutaka Ueda, Eisuke Amiya, Eiki Takimoto, Issei Komuro, Minoru Ono   +13 more
doaj   +1 more source

Experience with left ventricular assist device usage in the treatment of end-stage heart failure [PDF]

Кардіохірургія та інтервенційна кардіологія, 2017
Heart failure potentially developing in most of heart diseases is a progressive process associated with high morbidity and mortality. Almost 3/4 of patients die within five years after first hospitalization because of heart failure.
B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk   +10 more
doaj  

Ethical challenges with the left ventricular assist device as a destination therapy

Philosophy, Ethics, and Humanities in Medicine, 2008
The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure.
Rady Mohamed Y, Verheijde Joseph L, Rizzieri Aaron G, McGregor Joan L   +3 more
doaj   +1 more source

Case report: Facilitating right heart recovery after durable LVAD implantation through repair of atrioventricular valves and RVAD implantation using tunneled Dacron grafts

Frontiers in Cardiovascular Medicine, 2023
Right ventricular assist device (RVAD) weaning is often an important goal for durable left ventricular assist device support. This may be facilitated by mitral and tricuspid repair as well as by minimizing the trauma of RVAD decannulation by using Dacron
K. Candis Jones-Ungerleider, Syed Sikandar Raza, Paul C. Tang, Paul C. Tang   +3 more
doaj   +1 more source

Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation

Annals of Cardiac Anaesthesia, 2016
A growing number of patients are undergoing prolonged management of advanced heart failure with the use of continuous flow left ventricular assist devices (LVADs).
Beth T Webber, Anthony L Panos, Yiliam F Rodriguez-Blanco   +2 more
doaj   +1 more source

Successful heart transplantation following long-term left ventricular assist device support in a patient with peripartum cardiomyopathy: The first case in Serbia [PDF]

Srpski Arhiv za Celokupno Lekarstvo
Introduction. Peripartum cardiomyopathy (PPCM) is a rare and potentially life-threatening cause of heart failure occurring during late pregnancy or the early postpartum period.
Đurošev Ivana, Nestorović Emilija, Čubrilo Marko, Milošević Mikan, Terzić Duško   +4 more
doaj   +1 more source

Design and characteristics of the prophylactic intra‐operative ventricular arrhythmia ablation in high‐risk LVAD candidates (PIVATAL) trial

Annals of Noninvasive Electrocardiology, 2023
Background The use of a Left Ventricular Assist Device (LVAD) in patients with advanced heart failure refractory to optimal medical management has progressed steadily over the past two decades. Data have demonstrated reduced LVAD efficacy, worse clinical
David T. Huang, Igor Gosev, Katherine L. Wood, Hima Vidula, William Stevenson, Frank Marchlinski, Gregory Supple, Sandip K. Zalawadiya, J. Peter Weiss, Roderick Tung, Wendy S. Tzou, Joshua D. Moss, Krishna Kancharla, Sunit‐Preet Chaudhry, Parin J. Patel, Arfaat M. Khan, Claudio Schuger, Guy Rozen, Michael S. Kiernan, Gregory S. Couper, Marzia Leacche, Ezequiel J. Molina, Anand D. Shah, Michael Lloyd, Jakub Sroubek, Edward Soltesz, Kalyanam Shivkumar, Casey White, Sinan Tankut, Brent A. Johnson, Scott McNitt, Valentina Kutyifa, Wojciech Zareba, Ilan Goldenberg   +33 more
doaj   +1 more source

Left Ventricular Assist Device Outflow Cannula Obstruction

JACC: Case Reports, 2020
One of the dreaded complications of left ventricular assist device implantation is mechanical obstruction of the device secondary to pump thrombosis or mechanical outflow cannula obstruction.
Majid Asawaeer, MD, Sajid Kadir, MD, Arif Albulushi, MD, Anthony W. Castleberry, MD, Yiannis S. Chatzizisis, MD, PhD   +4 more
doaj   +1 more source